Regional Covid-19 Resources and On Reserve Stats by Region Below:
Black = New Cases, Green = Recovered, Red = Deaths, Blue – Hospitalized, Purple – ISC reported total –  Updated Daily

BC
2 181 76 2,914 3,009
AB
29 437 80 7,651 8,132
SK
17 186 61 6,597 6,759
MB
52 366 76 7,287 7,570
ON
8 78 30 1,901 2,012
QC
0 14 5 702 728
Atlantic
0 0 0 10 16
North60
20 13 6 658 796
 

Widgetized Section

Go to Admin » Appearance » Widgets » and move Gabfire Widget: Social into that MastheadOverlay zone

Johnson & Johnson vaccine recommended for Canadians 30 and older despite risk of rare blood clots – CBC

Canadians should weigh risk of rare condition against risk of serious COVID-19 complications, NACI says

May 03, 2021

Canada now recommends the Johnson & Johnson vaccine for all Canadians 30 years of age and older, but officials also say to weigh the risk of rare but potentially serious blood clots that can occur from the vaccine against COVID-19 levels in the community — or hold out for another shot altogether.

The National Advisory Committee on Immunization (NACI) said Monday that while the Johnson & Johnson vaccine will soon be distributed across Canada, it’s up to Canadians in that age group to decide whether they should take it or wait for an mRNA vaccine such as Pfizer-BioNTech or Moderna.

Health Canada approved the Johnson & Johnson vaccine in March and updated its labelling last week to acknowledge the risk of a rare but serious blood-clotting condition connected to the shot known as vaccine-induced immune thrombotic thrombocytopenia (VITT).

Read more: https://www.cbc.ca/news/health/naci-johnson-and-johnson-vaccine-blood-clot-risk-covid-19-1.6012102

NationTalk Partners & Sponsors Learn More